Previous 10 | Next 10 |
The Dow reached a 7-month high last Thursday and Nasdaq topped 8,000 on Wednesday as both indexes (and the S&P 500) are only a little over 1% below their all-time highs, set last fall. The biggest news last week was that the Apple ([[AAPL]]) and Qualcomm ([[QCOM]]) settlement on Tues...
Every Thursday night, Bespoke publishes a YTD return for all 11 sectors of the S&P 500, and last Thursday night's bar chart shows that the Healthcare sector was now negative for 2019 YTD, dramatically underperforming the S&P 500 YTD. Using IBES by Refinitiv actual earnings and revenu...
As if here weren't enough things for investors to worry about, a new fear is being talked about on Wall Street. Although corporate earnings are beating expectations, financial commentators are focused on the latest weakness in the healthcare sector. With the stocks of many biotech and pharmace...
This article was first released to CEF/ETF Income Laboratory subscribers two weeks ago, so data may be out of date. Please check latest data before making investment decisions. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movement...
This article was first released to CEF/ETF Income Laboratory subscribers two weeks ago. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund ((CEF)) sectors in the last week, as well as to highlight recently c...
For income investors, closed-end funds, or CEFs, are an attractive class of asset that promise high income generally in the range of 6-10%, broad diversification in terms of types of assets, and market matching total returns in the long term, if selected carefully. However, CEFs come with th...
Pharmaceutical companies are continuing to defy political pressure from both Democrats and Republicans by raising the prices of almost 3,000 drugs in the U.S. in the first three months of this year. More news on: Health Care Select Sect SPDR ETF, iShares U.S. Healthcare ETF, Vanguard Hea...
Tekla Healthcare Investors (the “Fund”) announced today that its Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding common shares for a one-year...
By Vinay Thapar Healthcare stocks served as powerful painkillers during last year's market declines. Yet the sector offers much more than just downside protection for investors who focus on business potential and resist the urge to predict scientific breakthroughs. While the MSCI World I...
This article was first released to subscribers 2 weeks ago. The Weekly Closed-End Fund Roundup will be put out at the start of each week to summarize recent price movements in closed-end fund ((CEF)) sectors in the last week, as well as to highlight recently concluded or upcoming corporate...
News, Short Squeeze, Breakout and More Instantly...
Tekla Healthcare Investors Company Name:
HQH Stock Symbol:
NYSE Market:
2024-04-22 03:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-04-02 07:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-23 06:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...